Faina Linkov1, Esther Elishaev2, Nika Gloyeske3, Robert Edwards4, Andrew D Althouse4, Melissa A Geller5, Charles Svendsen5, Peter A Argenta5. 1. University of Pittsburgh Department of Obstetrics, Gynecology, and Reproductive Sciences, Magee-Womens Research Institute, Pittsburgh, Pennsylvania. Electronic address: faina.linkov@gmail.com. 2. University of Pittsburgh School of Medicine, Department of Pathology, Pittsburgh, Pennsylvania. 3. SUNY Downstate, Department of Pathology, Brooklyn, New York. 4. University of Pittsburgh Department of Obstetrics, Gynecology, and Reproductive Sciences, Magee-Womens Research Institute, Pittsburgh, Pennsylvania. 5. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Minnesota, Minneapolis, Minnesota, USA.
Abstract
BACKGROUND: Obesity has been linked to abnormal estrogen regulation, endometrial hyperplasia, and endometrial cancer (EC). Our group has shown that hormone receptor expression profiles in the endometria of morbidly obese women change with weight loss, in some cases concordantly with resolving hyperplasia; however other potential drivers of neoplasia, including altered immunologic tolerance exist. The objective of this study was to evaluate the effect of bariatric surgery induced weight loss on the expression patterns of nonhormone receptor biomarkers associated with cancer and immunity. METHODS: Endometrial biopsies were obtained from 59 asymptomatic, morbidly obese women at the time of bariatric surgery and again 1 year postsurgery. Tissue microarrays were created and immunohistochemical stains for CD3, CD20, and PTEN were performed on all samples and evaluated by 2 blinded pathologists independently. Approximately 50% of participants had sufficient tissue for analysis at both visits. McNemar/Bowker tests of symmetry were performed to compare proportions between categories for matched pairs (pre- and post-treatment). RESULTS: Endometrial hyperplasia was identified in 4 women despite negative clinical histories and resolution of hyperplasia after weight loss occurred in 3 women. While overall no significant differences were observed between matched pre and postsurgery levels of CD20 and CD3 positive cells, a tendency toward decreased expression levels from baseline status was observed for CD20. No differences were observed for PTEN. CONCLUSION: Our data demonstrate that the prevalence of endometrial pathology appears to be partially mitigated by weight loss. Weight loss is associated with alterations in the hormone receptor profiles, but these data suggest that changes in the immune response, as measure be expression of CD20+, may be relevant targets for EC prevention research.
BACKGROUND: Obesity has been linked to abnormal estrogen regulation, endometrial hyperplasia, and endometrial cancer (EC). Our group has shown that hormone receptor expression profiles in the endometria of morbidly obesewomen change with weight loss, in some cases concordantly with resolving hyperplasia; however other potential drivers of neoplasia, including altered immunologic tolerance exist. The objective of this study was to evaluate the effect of bariatric surgery induced weight loss on the expression patterns of nonhormone receptor biomarkers associated with cancer and immunity. METHODS: Endometrial biopsies were obtained from 59 asymptomatic, morbidly obesewomen at the time of bariatric surgery and again 1 year postsurgery. Tissue microarrays were created and immunohistochemical stains for CD3, CD20, and PTEN were performed on all samples and evaluated by 2 blinded pathologists independently. Approximately 50% of participants had sufficient tissue for analysis at both visits. McNemar/Bowker tests of symmetry were performed to compare proportions between categories for matched pairs (pre- and post-treatment). RESULTS:Endometrial hyperplasia was identified in 4 women despite negative clinical histories and resolution of hyperplasia after weight loss occurred in 3 women. While overall no significant differences were observed between matched pre and postsurgery levels of CD20 and CD3 positive cells, a tendency toward decreased expression levels from baseline status was observed for CD20. No differences were observed for PTEN. CONCLUSION: Our data demonstrate that the prevalence of endometrial pathology appears to be partially mitigated by weight loss. Weight loss is associated with alterations in the hormone receptor profiles, but these data suggest that changes in the immune response, as measure be expression of CD20+, may be relevant targets for EC prevention research.
Authors: Xiaochen Zhang; Jennifer Rhoades; Bette J Caan; David E Cohn; Ritu Salani; Sabrena Noria; Adrian A Suarez; Electra D Paskett; Ashley S Felix Journal: Int J Gynecol Cancer Date: 2019-08-26 Impact factor: 3.437
Authors: Åsa Anveden; Magdalena Taube; Markku Peltonen; Peter Jacobson; Johanna C Andersson-Assarsson; Kajsa Sjöholm; Per-Arne Svensson; Lena M S Carlsson Journal: Gynecol Oncol Date: 2017-03-01 Impact factor: 5.482
Authors: D Abdulkhalikova; A Sustarsic; Eda Vrtačnik Bokal; N Jancar; M Jensterle; T Burnik Papler Journal: Front Endocrinol (Lausanne) Date: 2022-06-22 Impact factor: 6.055
Authors: Faina Linkov; Sharon L Goughnour; Shalkar Adambekov; Anna Lokshin; Joseph L Kelley; Paniti Sukumvanich; John T Comerci; Kacey G Marra; Lauren E Kokai; J Peter Rubin; Anda M Vlad; Brian J Philips; Robert P Edwards Journal: Biomark Med Date: 2018-07-25 Impact factor: 2.851
Authors: Anie Naqvi; Michelle L MacKintosh; Abigail E Derbyshire; Anna-Maria Tsakiroglou; Thomas D J Walker; Rhona J McVey; James Bolton; Martin Fergie; Steven Bagley; Garry Ashton; Philip W Pemberton; Akheel A Syed; Basil J Ammori; Richard Byers; Emma J Crosbie Journal: Int J Obes (Lond) Date: 2021-12-02 Impact factor: 5.551